Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
896.90
+3.55 (0.40%)
Jan 28, 2026, 3:30 PM IST
Zydus Lifesciences Revenue
Zydus Lifesciences had revenue of 61.23B INR in the quarter ending September 30, 2025, with 16.92% growth. This brings the company's revenue in the last twelve months to 244.94B, up 14.01% year-over-year. In the fiscal year ending March 31, 2025, Zydus Lifesciences had annual revenue of 232.42B with 18.90% growth.
Revenue (ttm)
244.94B
Revenue Growth
+14.01%
P/S Ratio
3.67
Revenue / Employee
8.77M
Employees
27,917
Market Cap
898.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 232.42B | 36.94B | 18.90% |
| Mar 31, 2024 | 195.47B | 23.10B | 13.40% |
| Mar 31, 2023 | 172.37B | 21.28B | 14.08% |
| Mar 31, 2022 | 151.10B | 7.06B | 4.90% |
| Mar 31, 2021 | 144.04B | 1.50B | 1.06% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 325.14B |
| Cipla | 279.67B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
| Divi's Laboratories | 100.29B |
| Ipca Laboratories | 93.59B |
| Emcure Pharmaceuticals | 84.49B |
Zydus Lifesciences News
- 1 day ago - Stocks to watch today, Jan 27: Infosys, Adani Enterprises, Zydus Lifesciences, ONGC, Bank of Baroda and more - Business Upturn
- 6 days ago - Zydus Lifesciences launches world’s first biosimilar of Nivolumab, ‘Tishtha’ in India - Business Upturn
- 7 days ago - Ardelyx (ARDX) Surges on Potential Acquisition by Zydus Lifesciences - GuruFocus
- 7 days ago - Ardelyx gains on report Zydus Lifesciences in talks to purchase - Seeking Alpha
- 15 days ago - Zydus Lifesciences’ US arm Sentynl secures FDA approval for ZYCUBO, first-ever treatment for Menkes disease - Business Upturn
- 15 days ago - Delhi HC clears Zydus biosimilar, boosting access to affordable cancer care - The Times of India
- 5 weeks ago - Zydus Lifesciences, Bioeq Sign Agreement To Commercialize NUFYMCO In US - Nasdaq
- 5 weeks ago - Zydus Lifesciences shares in focus today after High Court allows semaglutide manufacturing for exports - Business Upturn